What SEC filings are tracked for $RPRX (Royalty Pharma plc)?

Position Tracker indexes 2 SEC EDGAR filings for Royalty Pharma plc ($RPRX), including 0 Form 10-K annual reports, 1 Form 10-Q quarterly reports, 1 Form 8-K material event disclosures, and 0 Form 4 insider buying and selling filings.

When was the most recent $RPRX (Royalty Pharma plc) SEC filing?

The latest tracked SEC EDGAR filing for Royalty Pharma plc ($RPRX) was filed on November 4, 2026, with 0 high-impact or featured filings flagged by Position Tracker's AI analysis.

$RPRX SEC EDGAR Filings Hub 2 Filings

$RPRX · Royalty Pharma plc SEC Filings

Position Tracker tracks 2 SEC EDGAR filings for Royalty Pharma plc ($RPRX) from November 4, 2026 through November 4, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.

Check $RPRX portfolio concentration → View $RPRX Congress trades → Research $RPRX stock → All SEC filings →

Total Filings2

10-K / 10-Q Reports1

8-K Material Events1

Form 4 Insider0

High-Impact0

Latest FilingNovember 4, 2026

Browse SEC Filings by Form Type

Form 4 Form 8-K Form 10-K Form 10-Q Schedule 13D/13G Form 13F Form S-1 Form 6-K

Latest $RPRX SEC Filings & AI Summaries (2)

$RPRX Form 10-Q Impact 6/10 Earnings

November 4, 2026

$RPRX 10-Q — Royalty Pharma plc

N/A

Read AI filing analysis → SEC.gov filing ↗

$RPRX Form 8-K Impact 6/10 Earnings

November 4, 2026

$RPRX 8-K — Royalty Pharma plc

A guidance raise paired with a large impairment shows both the compounding power and the clinical risk embedded in Royalty Pharma's royalty portfolio.

Read AI filing analysis → SEC.gov filing ↗

$RPRX · Royalty Pharma plc SEC Filings

$RPRX 10-Q — Royalty Pharma plc

$RPRX 8-K — Royalty Pharma plc

Get real-time alerts when $RPRX files a new 10-K, 10-Q, 8-K, or Form 4.